Dr. Brian Wolpin was featured in the Lustgarten newsletter with the focus on personalized medicine. Read the story.
“In approximately one-third of patients, we find a mutation or genetic alteration that can be treated with a therapy that is either in clinical trials or used for other types of cancer,” said Dr. Wolpin.
